These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31431457)

  • 1. Nanoparticle Encapsulation of Synergistic Immune Agonists Enables Systemic Codelivery to Tumor Sites and IFNβ-Driven Antitumor Immunity.
    Atukorale PU; Raghunathan SP; Raguveer V; Moon TJ; Zheng C; Bielecki PA; Wiese ML; Goldberg AL; Covarrubias G; Hoimes CJ; Karathanasis E
    Cancer Res; 2019 Oct; 79(20):5394-5406. PubMed ID: 31431457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-enveloped zinc phosphate hybrid nanoparticles for codelivery of H-2K(b) and H-2D(b)-restricted antigenic peptides and monophosphoryl lipid A to induce antitumor immunity against melanoma.
    Zhuang X; Wu T; Zhao Y; Hu X; Bao Y; Guo Y; Song Q; Li G; Tan S; Zhang Z
    J Control Release; 2016 Apr; 228():26-37. PubMed ID: 26921522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulatory nanoparticle incorporating two immune agonists for the treatment of pancreatic tumors.
    Lorkowski ME; Atukorale PU; Bielecki PA; Tong KH; Covarrubias G; Zhang Y; Loutrianakis G; Moon TJ; Santulli AR; Becicka WM; Karathanasis E
    J Control Release; 2021 Feb; 330():1095-1105. PubMed ID: 33188827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
    Bielecki PA; Lorkowski ME; Becicka WM; Atukorale PU; Moon TJ; Zhang Y; Wiese M; Covarrubias G; Ravichandran S; Karathanasis E
    Nanoscale Horiz; 2021 Feb; 6(2):156-167. PubMed ID: 33400743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the uptake of untargeted and targeted immunostimulatory nanoparticles by immune cells in the microenvironment of metastatic breast cancer.
    Covarrubias G; Moon TJ; Loutrianakis G; Sims HM; Umapathy MP; Lorkowski ME; Bielecki PA; Wiese ML; Atukorale PU; Karathanasis E
    J Mater Chem B; 2022 Jan; 10(2):224-235. PubMed ID: 34846443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.
    Hanson MC; Crespo MP; Abraham W; Moynihan KD; Szeto GL; Chen SH; Melo MB; Mueller S; Irvine DJ
    J Clin Invest; 2015 Jun; 125(6):2532-46. PubMed ID: 25938786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.
    Cheng N; Watkins-Schulz R; Junkins RD; David CN; Johnson BM; Montgomery SA; Peine KJ; Darr DB; Yuan H; McKinnon KP; Liu Q; Miao L; Huang L; Bachelder EM; Ainslie KM; Ting JP
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Activation of cGAS for Cancer Immunotherapy.
    Garland KM; Rosch JC; Carson CS; Wang-Bishop L; Hanna A; Sevimli S; Van Kaer C; Balko JM; Ascano M; Wilson JT
    Front Immunol; 2021; 12():753472. PubMed ID: 34899704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of α-GalCer analog and TLR4 agonist induces robust CD8(+) T-cell responses to PyCS protein and WT-1 antigen and activates memory-like effector NKT cells.
    Coelho-Dos-Reis JG; Huang J; Tsao T; Pereira FV; Funakoshi R; Nakajima H; Sugiyama H; Tsuji M
    Clin Immunol; 2016 Jul; 168():6-15. PubMed ID: 27132023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8
    Watanabe T; Gaedicke S; Guffart E; Firat E; Niedermann G
    Clin Cancer Res; 2020 Feb; 26(4):945-956. PubMed ID: 31694834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers.
    Shen L; Li J; Liu Q; Song W; Zhang X; Tiruthani K; Hu H; Das M; Goodwin TJ; Liu R; Huang L
    ACS Nano; 2018 Oct; 12(10):9830-9841. PubMed ID: 30253648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of necrotic cell death and activation of STING in the tumor microenvironment via cationic silica nanoparticles leading to enhanced antitumor immunity.
    An M; Yu C; Xi J; Reyes J; Mao G; Wei WZ; Liu H
    Nanoscale; 2018 May; 10(19):9311-9319. PubMed ID: 29737353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell activation by an E. coli-derived monophosphoryl lipid A enhances the efficacy of PD-1 blockade.
    Jeong Y; Kim GB; Ji Y; Kwak GJ; Nam GH; Hong Y; Kim S; An J; Kim SH; Yang Y; Chung HS; Kim IS
    Cancer Lett; 2020 Mar; 472():19-28. PubMed ID: 31857157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice.
    Van De Voort TJ; Felder MA; Yang RK; Sondel PM; Rakhmilevich AL
    J Immunother; 2013 Jan; 36(1):29-40. PubMed ID: 23211623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    McAndrews KM; Che SPY; LeBleu VS; Kalluri R
    J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Zhao L; Huang S; Mei S; Yang Z; Xu L; Zhou N; Yang Q; Shen Q; Wang W; Le X; Lau WB; Lau B; Wang X; Yi T; Zhao X; Wei Y; Warner M; Gustafsson JÅ; Zhou S
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3673-E3681. PubMed ID: 29592953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma.
    Nakamura T; Miyabe H; Hyodo M; Sato Y; Hayakawa Y; Harashima H
    J Control Release; 2015 Oct; 216():149-57. PubMed ID: 26282097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.